Policy Analysis: Life Sciences, Policy
Published:

Patients take control of innovation

Despite industry’s endless lip service to driving innovation for the benefit of patients, many diseases go untreated. Now, sick of being passive recipients, patients are taking control and shaping innovation to their real needs

Michel Goldman, Director of IMI

The paternalistic model for delivering healthcare innovation, in which patients are passive subjects for testing news drugs or procedures - and grateful recipients of any resulting products - is coming to an end.

The Michael J Fox Foundation provides the most recent example of patient power in action. Rather than wait any longer for the old-fashioned model to deliver a reliable diagnostic, the research charity sealed an agreement last week with the drug discovery services specialist BioFocus,...



Related subjects: European Medicines Agency

The 2015 Science|Business Annual Summit
The Science|Business Annual Summit brings together leaders from research, industry and policy to debate current and future trends needed to unleash Europe’s technological potential.
Barcelona - 20 November 2015
The future of manufacturing: Industry 4.0 (Date to be confirmed)
A Science|Business public conference
Brussels - 01 October 2015
The Bioeconomy Challenge: Producing more from less
A Science|Business high-level roundtable
Brussels - 29 September 2015
Views of 2030: Transport, manufacturing, education and health
In October 2014, members of the Science|Business Network of universities and companies met in Berlin to compare notes about the future of four key sectors in Europe. This is what they see coming.